PD

Purnima Dhanraj Amin

Active Director Director DIN 11461111
DIN 11461111 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Purnima Dhanraj Amin

Data last updated:

Purnima Dhanraj Amin is a Director at Bajaj Healthcare Limited (since 2026). The company operates in Pharma.

DIN 11461111
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2026
Oldest Company Age 33 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bajaj Healthcare Limited L99999MH1993PLC072892
Director05 Jan 20261993Active

Directorship timeline

Open interactive timeline →
Bajaj Healthcare Limited
Premium access

Shareholding and investment profile for Purnima Dhanraj Amin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Purnima Dhanraj Amin

Purnima Dhanraj Amin currently holds 1 directorship: Bajaj Healthcare Limited (Director, since 05 Jan 2026).

Purnima Dhanraj Amin was first appointed on 05 Jan 2026 as Director at Bajaj Healthcare Limited.

The current boards of Purnima Dhanraj Amin's companies include Anil Champalal Jain (Bajaj Healthcare Limited), Gopalakrishnan Kesavan (Bajaj Healthcare Limited), Kejal Niken Shah (Bajaj Healthcare Limited), Monica Tanwar (Bajaj Healthcare Limited), Namrata Sajankumar Bajaj (Bajaj Healthcare Limited), Pakshal Anil Jain (Bajaj Healthcare Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available